Elbit Medical Technologies Ltd (EMTC-M.TA)
ILA 24.2
(0.0%)
ILA 24.2
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 197 Thousand USD | -62.26% |
| 2022 | 522 Thousand USD | -7.45% |
| 2021 | 564 Thousand USD | -98.47% |
| 2020 | 36.97 Million USD | -26.77% |
| 2019 | 50.48 Million USD | 15.99% |
| 2018 | 43.52 Million USD | 2.47% |
| 2017 | 42.47 Million USD | 14.23% |
| 2016 | 37.18 Million USD | 9.35% |
| 2015 | 34 Million USD | 4.42% |
| 2014 | 32.56 Million USD | -3.7% |
| 2013 | 33.81 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 161 Thousand USD | -18.27% |
| 2024 Q2 | 161 Thousand USD | 0.0% |
| 2023 Q2 | 230 Thousand USD | 0.0% |
| 2023 FY | 197 Thousand USD | -62.26% |
| 2023 Q4 | 197 Thousand USD | 0.0% |
| 2023 Q3 | 197 Thousand USD | -14.35% |
| 2023 Q1 | 230 Thousand USD | -55.94% |
| 2022 Q4 | 522 Thousand USD | 0.0% |
| 2022 Q1 | 654 Thousand USD | 15.96% |
| 2022 Q2 | 654 Thousand USD | 0.0% |
| 2022 FY | 522 Thousand USD | -7.45% |
| 2022 Q3 | 522 Thousand USD | -20.18% |
| 2021 Q2 | 38.54 Million USD | 5.94% |
| 2021 FY | 564 Thousand USD | -98.47% |
| 2021 Q4 | 564 Thousand USD | 0.0% |
| 2021 Q1 | 36.38 Million USD | -1.6% |
| 2021 Q3 | 564 Thousand USD | -98.54% |
| 2020 Q4 | 36.97 Million USD | 13.26% |
| 2020 FY | 36.97 Million USD | -26.77% |
| 2020 Q1 | 48.87 Million USD | -3.19% |
| 2020 Q2 | 35.56 Million USD | -27.24% |
| 2020 Q3 | 32.64 Million USD | -8.21% |
| 2019 Q3 | 48.9 Million USD | 5.53% |
| 2019 Q2 | 46.34 Million USD | 4.24% |
| 2019 FY | 50.48 Million USD | 15.99% |
| 2019 Q1 | 44.45 Million USD | 2.14% |
| 2019 Q4 | 50.48 Million USD | 3.23% |
| 2018 FY | 43.52 Million USD | 2.47% |
| 2018 Q2 | 47.07 Million USD | 0.0% |
| 2018 Q1 | - USD | -100.0% |
| 2018 Q4 | 43.52 Million USD | 0.0% |
| 2017 FY | 42.47 Million USD | 14.23% |
| 2017 Q1 | 40.74 Million USD | 9.57% |
| 2017 Q2 | 40.74 Million USD | 0.0% |
| 2017 Q3 | 42.47 Million USD | 4.26% |
| 2017 Q4 | 42.47 Million USD | 0.0% |
| 2016 FY | 37.18 Million USD | 9.35% |
| 2016 Q4 | 37.18 Million USD | -0.87% |
| 2016 Q3 | 37.5 Million USD | 4.33% |
| 2016 Q2 | 35.95 Million USD | 2.26% |
| 2016 Q1 | 35.15 Million USD | 3.4% |
| 2015 FY | 34 Million USD | 4.42% |
| 2015 Q1 | 31.73 Million USD | -2.55% |
| 2015 Q2 | 33.14 Million USD | 4.45% |
| 2015 Q3 | 33.08 Million USD | -0.2% |
| 2015 Q4 | 34 Million USD | 2.79% |
| 2014 Q1 | 35.84 Million USD | 6.0% |
| 2014 Q3 | 32.68 Million USD | -2.55% |
| 2014 Q4 | 32.56 Million USD | -0.38% |
| 2014 Q2 | 33.54 Million USD | -6.41% |
| 2014 FY | 32.56 Million USD | -3.7% |
| 2013 Q4 | 33.81 Million USD | 5.06% |
| 2013 Q3 | 32.18 Million USD | 5.99% |
| 2013 Q1 | 29.37 Million USD | 0.0% |
| 2013 FY | 33.81 Million USD | 0.0% |
| 2013 Q2 | 30.36 Million USD | 3.39% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|